Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.
Cochrane Database Syst Rev
; 6: CD012066, 2023 06 05.
Article
in En
| MEDLINE
| ID: mdl-37276335
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumonia
/
Pulmonary Disease, Chronic Obstructive
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
/
Systematic_reviews
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cochrane Database Syst Rev
Journal subject:
PESQUISA EM SERVICOS DE SAUDE
Year:
2023
Type:
Article
Affiliation country:
Japan